Category Archives: TB

When do you start HIV treatment in patients with TB?

By on .

Given the synergistic epidemics of HIV and TB in southern Africa, the question of how and when to integrate HIV and TB treatment in co-infected patients is a critical one. Here at the Conference on Retroviruses and Opportunistic Infections, Drs. Diane Havlir and Salim Abdool Karim presented important results from two randomized clinical trials attempting […]

What’s next in TB: Expert Q&A with Dr. Peter Small of the Gates Foundation

By on .

In the second of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, John Donnelly speaks with Dr. Peter Small, who runs the tuberculosis program at the Gates Foundation, regarding his thoughts on recent developments in the field of TB control and treatment, including the promise of the Gene Xpert rapid TB diagnostic tool. Dr. Small is a member of the Stop TB Partnership’s Coordinating Board, has done extensive research in the genetic variability of tuberculosis, and is a global expert in TB epidemiology, biology and control.

Gates Foundation’s Dr. Bertozzi talks about what’s to come for HIV and TB

By on .

In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.

USAID Administrator discusses “transformational goals” to include curing 2.4 million infected with TB

By on .

In a prestigious lecture to the National Institutes of Health (NIH) scientific community Tuesday, U.S. Agency on International Development (USAID) Administrator Rajiv Shah spoke about efficiencies that can be gained under the Global Health Initiative (GHI) and a renewed focus on “facilitating a continuum of invention and innovation from bench to bush,” at the agency.

USAID describes impact of possible TB funding cuts

By on .

In a presentation made to TB advocates and implementers, representatives from the U.S. Agency for International Development’s (USAID) Bureau for Global Health described the range of cuts its TB programs would experience if flat funded at the fiscal year (FY) 2010 level,  or a reduction to the FY 2008 level. These budgetary scenarios were presented as […]

USAID report outlines priorities in TB research and development

By on .

The U.S. Agency on International Development (USAID) issued a report to Congress entitled “Health Related Research and Development Activities at USAID – An Update on the Five-year Strategy, 2006 – 2010” and has been releasing the report to the public in increments since October. Science Speaks reported on the release of the AIDS research chapter […]

Groundbreaking GeneXpert may evolve to measure HIV viral load in addition to TB diagnostic capacity

By on .

Cepheid, a California-based molecular diagnostics company, and the Foundation for Innovative New Diagnostics (FIND) announced a new collaboration to accelerate the development of a rapid HIV viral load test.  This viral load test will run on the platform of Cepheid’s GeneXpert, the ground-breaking rapid test to diagnose drug-susceptible and drug-resistant tuberculosis.  Given the high rates […]